Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2016-02 ,pp. : 815-825

Karger

Access to resources Recommend Favorite

Dopamine D₂-Receptor Activation Differentially Inhibits N- and R-Type Ca²⁺ Channels in Xenopus Melanotrope Cells

By  

Neuroendocrinology, Vol. 80, Iss. 6, 2005-05 ,pp. : 368-378

Karger

Access to resources Recommend Favorite

Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role

By  

Neuroendocrinology, Vol. 101, Iss. 3, 2015-02 ,pp. : 211-222

Karger

Access to resources Recommend Favorite

Differential Inhibition of Growth Hormone Secretion by Analogs Selective for Somatostatin Receptor Subtypes 2 and 5 in Human Growth-Hormone-Secreting Adenoma Cells in vitro

By  

Neuroendocrinology, Vol. 73, Iss. 5, 2001-05 ,pp. : 344-351

Karger

Access to resources Recommend Favorite

Urocortin and Corticotropin-Releasing Hormone Receptor Type 2 Expression in the Human Gallbladder

By  

Neuroendocrinology, Vol. 82, Iss. 3-4, 2006-05 ,pp. : 177-184

Karger

Access to resources Recommend Favorite